Topic
5 claims checked
Claim:
Thousands of people have reported severe side effects from Ozempic (semaglutide), including blindness and organ damage.
HARDLY BS
Claim:
Novo Nordisk is facing a lawsuit seeking US$2 billion in damages related to Ozempic.
TOTAL BS
Claim:
Use of Ozempic is associated with changes in taste perception and reduced enjoyment of eating.
HARDLY BS
Claim:
Ozempic and similar GLP-1 drugs have contributed to a reduction in United States obesity rates for the first time in decades.
HARDLY BS
Claim:
The use of weight-loss drugs such as Ozempic and Wegovy will significantly impact public health outcomes by 2036.
HARDLY BS